DETROIT (AP) — A Detroit-based health system is enrolling children ages 6 months to 11 years old for Moderna's COVID-19 vaccine study.
Henry Ford Health System says Thursday that the KidCOVE study will evaluate the safety and effectiveness of the pharma company's mRNA-1273 vaccine for that age group. The mRNA-1273 is the same vaccine given emergency use authorization by the FDA for people 18 and older.
Participation in the KidCOVE study will last about 14 months and require both in-person clinic visits and virtual visits. Participants will receive one injection about 28 days apart. The health system says neither the participants or their parents will know whether they received the study vaccine or a placebo injection.
Additional Coronavirus information and resources:
View a global coronavirus tracker with data from Johns Hopkins University.
See complete coverage on our Coronavirus Continuing Coverage page.
Visit our The Rebound Detroit, a place where we are working to help people impacted financially from the coronavirus. We have all the information on everything available to help you through this crisis and how to access it.